Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 210

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 210
---
 compensation of a public company’s executive officers (other than the chief executive officer and who do not also serve as a
director) be approved in the following order: (i) the compensation committee, (ii) the company’s board of directors, and (iii) if
such compensation arrangement is inconsistent with the company’s stated compensation policy, the company’s shareholders (by
a special vote as discussed above with respect to the approval of director compensation that is inconsistent with the compensation policy).

However, there are exceptions
to the foregoing approval requirements with respect to such non-director executive officers. If the shareholders of the company do not
approve the compensation of such a non-director executive officer, the compensation committee and board of directors may override the
shareholders’ disapproval for such non-director executive officer provided that the compensation committee and the board of directors
each document the basis for their decision to override the disapproval of the shareholders and approve the compensation.

An amendment to an existing
compensation arrangement with a non-director executive officer requires only the approval of the compensation committee, if the compensation
committee determines that the amendment is immaterial. However, if such non-director executive officer is subordinate to the chief executive
officer, an immaterial amendment to an existing compensation arrangement shall not require the approval of the compensation committee
if (i) such amendment is approved by the chief executive officer, (ii) the company’s compensation policy allows for such immaterial
amendments to be approved by the chief executive officer and (iii) the engagement terms are consistent with the company’s compensation
policy.

Chief executive officer

Under the Companies Law, the
compensation of a public company’s chief executive officer is required to be approved by: (i) the company’s compensation committee,
(ii) the company’s board of directors and (iii) the company’s shareholders (by a special vote as discussed above with respect
to the approval of director compensation that is inconsistent with the compensation policy). However, if the shareholders of the company
do not approve the compensation arrangement with a chief executive officer who does not serve as a director, the compensation committee
and board of directors may override the shareholders’ decision provided that they each document the basis for their decision and
the compensation is in accordance with the company’s compensation policy. The approval of each of the compensation committee and
board of directors should be in accordance with the company’s compensation policy; however, in special circumstances, they may approve
compensation terms of a chief executive officer